ArticleBiologics : targets & therapy2013

Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib.

Ajay Nooka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.